NO20083042L - Indolinforbindelser anvendelige ved behandling av kognitiv svekkelse - Google Patents
Indolinforbindelser anvendelige ved behandling av kognitiv svekkelseInfo
- Publication number
- NO20083042L NO20083042L NO20083042A NO20083042A NO20083042L NO 20083042 L NO20083042 L NO 20083042L NO 20083042 A NO20083042 A NO 20083042A NO 20083042 A NO20083042 A NO 20083042A NO 20083042 L NO20083042 L NO 20083042L
- Authority
- NO
- Norway
- Prior art keywords
- cognitive impairment
- treatment
- compounds useful
- indoline compounds
- subject
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 5
- 208000028698 Cognitive impairment Diseases 0.000 title abstract 3
- 125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 title 1
- FGFUBBNNYLNVLJ-UHFFFAOYSA-N indolone Natural products C1=CC=C2C(=O)C=NC2=C1 FGFUBBNNYLNVLJ-UHFFFAOYSA-N 0.000 abstract 1
- -1 indolone compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74885105P | 2005-12-09 | 2005-12-09 | |
| PCT/US2006/046826 WO2007070362A1 (en) | 2005-12-09 | 2006-12-08 | Indolone compounds useful to treat cognitive impairment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20083042L true NO20083042L (no) | 2008-09-08 |
Family
ID=37903540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20083042A NO20083042L (no) | 2005-12-09 | 2008-07-09 | Indolinforbindelser anvendelige ved behandling av kognitiv svekkelse |
Country Status (23)
| Country | Link |
|---|---|
| EP (2) | EP2241316A1 (is) |
| JP (1) | JP5336194B2 (is) |
| KR (1) | KR20080077646A (is) |
| CN (1) | CN101378750B (is) |
| AT (1) | ATE480234T1 (is) |
| AU (1) | AU2006326665B2 (is) |
| BG (1) | BG110157A (is) |
| BR (1) | BRPI0620034A2 (is) |
| CA (1) | CA2633829A1 (is) |
| CZ (1) | CZ2008423A3 (is) |
| DE (1) | DE602006016849D1 (is) |
| EA (1) | EA200870027A1 (is) |
| ES (1) | ES2349675T3 (is) |
| HR (1) | HRP20080254A2 (is) |
| IL (1) | IL192022A0 (is) |
| IS (1) | IS8733A (is) |
| MX (1) | MX2008007377A (is) |
| NO (1) | NO20083042L (is) |
| PL (1) | PL386471A1 (is) |
| RS (1) | RS20080257A (is) |
| SK (1) | SK500262008A3 (is) |
| WO (1) | WO2007070362A1 (is) |
| ZA (1) | ZA200805285B (is) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2527324A4 (en) | 2010-01-20 | 2013-08-07 | Mitsubishi Gas Chemical Co | CYANATE STARTER COMPOUND AND HARDENING PRODUCT THEREOF |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK69693D0 (da) * | 1993-06-14 | 1993-06-14 | Neurosearch As | Farven lilla |
| US20030078271A1 (en) | 2001-01-31 | 2003-04-24 | Blackburn Thomas P. | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| TW200410937A (en) * | 2002-08-07 | 2004-07-01 | Synaptic Pharma Corp | 3-imino-2-indolones for the treatment of depression and/or anxiety |
| WO2004014307A2 (en) * | 2002-08-07 | 2004-02-19 | Synaptic Pharmaceutical Corporation | Gal3 antagonists for the treatment of neuropathic pain |
| WO2004014376A1 (en) * | 2002-08-07 | 2004-02-19 | Synaptic Pharmaceutical Corporation | Gal3 receptor antagonists for the treatment of affective disorders |
-
2006
- 2006-12-08 PL PL386471A patent/PL386471A1/pl not_active Application Discontinuation
- 2006-12-08 JP JP2008544527A patent/JP5336194B2/ja not_active Expired - Fee Related
- 2006-12-08 KR KR1020087015512A patent/KR20080077646A/ko not_active Ceased
- 2006-12-08 WO PCT/US2006/046826 patent/WO2007070362A1/en not_active Ceased
- 2006-12-08 AT AT06845000T patent/ATE480234T1/de not_active IP Right Cessation
- 2006-12-08 EA EA200870027A patent/EA200870027A1/ru unknown
- 2006-12-08 DE DE602006016849T patent/DE602006016849D1/de active Active
- 2006-12-08 AU AU2006326665A patent/AU2006326665B2/en not_active Ceased
- 2006-12-08 RS RSP-2008/0257A patent/RS20080257A/sr unknown
- 2006-12-08 CN CN2006800523099A patent/CN101378750B/zh not_active Expired - Fee Related
- 2006-12-08 HR HR20080254A patent/HRP20080254A2/xx not_active Application Discontinuation
- 2006-12-08 BR BRPI0620034-6A patent/BRPI0620034A2/pt not_active IP Right Cessation
- 2006-12-08 CZ CZ20080423A patent/CZ2008423A3/cs unknown
- 2006-12-08 EP EP10171823A patent/EP2241316A1/en not_active Withdrawn
- 2006-12-08 ES ES06845000T patent/ES2349675T3/es active Active
- 2006-12-08 CA CA002633829A patent/CA2633829A1/en not_active Abandoned
- 2006-12-08 ZA ZA200805285A patent/ZA200805285B/xx unknown
- 2006-12-08 EP EP06845000A patent/EP1957067B1/en not_active Not-in-force
- 2006-12-08 SK SK50026-2008A patent/SK500262008A3/sk unknown
- 2006-12-08 MX MX2008007377A patent/MX2008007377A/es active IP Right Grant
-
2008
- 2008-06-09 BG BG110157A patent/BG110157A/en unknown
- 2008-06-10 IL IL192022A patent/IL192022A0/en unknown
- 2008-06-12 IS IS8733A patent/IS8733A/is unknown
- 2008-07-09 NO NO20083042A patent/NO20083042L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL192022A0 (en) | 2009-08-03 |
| WO2007070362A1 (en) | 2007-06-21 |
| PL386471A1 (pl) | 2009-04-14 |
| EA200870027A1 (ru) | 2009-12-30 |
| HK1127736A1 (en) | 2009-10-02 |
| BRPI0620034A2 (pt) | 2011-10-25 |
| ATE480234T1 (de) | 2010-09-15 |
| EP1957067A1 (en) | 2008-08-20 |
| HRP20080254A2 (hr) | 2008-09-30 |
| IS8733A (is) | 2008-06-20 |
| EP2241316A1 (en) | 2010-10-20 |
| AU2006326665B2 (en) | 2012-11-15 |
| AU2006326665A1 (en) | 2007-06-21 |
| RS20080257A (sr) | 2009-05-06 |
| BG110157A (en) | 2008-12-30 |
| CN101378750A (zh) | 2009-03-04 |
| ZA200805285B (en) | 2009-12-30 |
| DE602006016849D1 (de) | 2010-10-21 |
| EP1957067B1 (en) | 2010-09-08 |
| CN101378750B (zh) | 2012-07-18 |
| JP5336194B2 (ja) | 2013-11-06 |
| SK500262008A3 (sk) | 2009-03-05 |
| KR20080077646A (ko) | 2008-08-25 |
| CA2633829A1 (en) | 2007-06-21 |
| CZ2008423A3 (cs) | 2009-08-05 |
| JP2009518431A (ja) | 2009-05-07 |
| MX2008007377A (es) | 2008-10-29 |
| ES2349675T3 (es) | 2011-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200600048A1 (ru) | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором | |
| MY144483A (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
| BRPI0607017A2 (pt) | métodos e composições para o tratamento de condições relacionadas ao snc | |
| MX2008006076A (es) | Metodos, composiciones y kits para el tratamiento de condiciones medicas. | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| WO2006105516A3 (en) | Compositions and methods for diagnosing and treating neuropsychiatric disorders | |
| EA201000895A1 (ru) | Композиции и способы для лечения лизосомных болезней | |
| WO2005039504A3 (en) | Compounds and methods for treating toll-like receptor 2-related diseases and conditions | |
| SG155163A1 (en) | Pharmacokinetically improved compounds | |
| EA201071243A1 (ru) | Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом | |
| WO2008155533A3 (en) | Phenothiazine compounds for treating mild cognitive impairment | |
| EP2453024A3 (en) | Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder | |
| WO2010075280A3 (en) | Coumarin-based compounds for the treatment of alzheimer's disease and cancer | |
| ATE456955T1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
| MX2007016469A (es) | Metodos de tratamiento utilizando ansamicinas de hidroquinona. | |
| BRPI0509660A (pt) | compostos de beta-carbolina de utilidade no tratamento de doenças inflamatórias | |
| EA200970436A1 (ru) | Соединения карбамата для лечения депрессии | |
| NO20083042L (no) | Indolinforbindelser anvendelige ved behandling av kognitiv svekkelse | |
| TW200735868A (en) | Compositions and methods for treating CNS disorders | |
| WO2004047727A3 (en) | Compositions and methods for diagnosing and treating mood disorders | |
| MX2009005351A (es) | Compuestos utiles para tratar trastornos neurodegenerativos. | |
| TW200742580A (en) | Methods for treating nephrolithiasis | |
| HU0201394D0 (is) | ||
| TW200744577A (en) | Method for treating osteoarthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |